Related Experiment Video
Updated: May 31, 2026
10:14
Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
Viral-associated thrombotic microangiopathies.
1Hospital Santo António dos Capuchos, Centro Hospitalar Lisboa Center, Alameda Capuchos, Lisboa, Portugal. ronolosi@gmail.com
Hematology/Oncology and Stem Cell Therapy
|July 6, 2011
Summary
Viral infections can trigger thrombotic microangiopathies, a serious condition causing anemia and organ failure. This review explores how viruses damage blood vessels, leading to these life-threatening disorders.
Area of Science:
- Hematology
- Infectious Diseases
- Pathology
Background:
- Thrombotic microangiopathies (TM) are characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ failure.
- Known causes include genetic factors, autoimmune disorders, cancer, drugs, transplantation, and infections like E. coli.
- Emerging evidence implicates viruses as significant triggers in TM pathogenesis.
Purpose of the Study:
- To provide a comprehensive review of viral-associated thrombotic microangiopathies.
- To elucidate the mechanisms of viral-induced endothelial damage in TM.
- To consolidate current understanding of viruses as triggers for this multisystemic disorder.
Main Methods:
- Literature review of studies on viral infections and thrombotic microangiopathies.
- Analysis of evidence linking viral pathogens to endothelial dysfunction.
- Synthesis of data on viral triggers and TM development.
Main Results:
- Viruses are increasingly recognized as important factors in TM development.
- Viral infections can induce endothelial stimulation and damage, initiating TM.
- This review highlights the role of viruses in the pathogenesis of life-threatening TM.
Conclusions:
- Viral infections represent a critical, yet often overlooked, etiological factor in thrombotic microangiopathies.
- Understanding viral-induced endothelial damage is key to managing TM.
- Further research into viral triggers is essential for improved patient outcomes.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...